Tirzepatide – For Research Use Only

Available Sizes

• 10mg — $106
• 20mg — $149
• 30mg — $191
• 40mg — $234
• 50mg — $255
• 60mg — $298

About Tirzepatide

Tirzepatide is a synthetic dual GIP/GLP-1 receptor co-agonist peptide. It simultaneously activates both the glucose-dependent insulinotropic polypeptide receptor (GIPR) and the glucagon-like peptide-1 receptor (GLP-1R), representing a novel dual incretin receptor targeting approach studied extensively in metabolic biology research. Its unique dual-agonist mechanism provides researchers with a tool to investigate the synergistic effects of GIP and GLP-1 receptor co-activation on insulin secretion dynamics, glucagon suppression, gastric motility, and adipose tissue metabolism in preclinical models.

Research Context

• Dual GIP/GLP-1 receptor co-agonism pharmacology
• Incretin axis biology and pancreatic beta-cell function studies
• Adipose tissue lipolysis and energy homeostasis research
• Comparative studies vs. mono-agonist GLP-1 analogues

Specs

• Purity: 99%+
• Form: Lyophilized powder
• Storage: −20°C long-term; 2–8°C short-term
• COA: Available every batch

For research use only. Not for human or animal use. Buyer is responsible for compliance with all applicable laws.